-
1
-
-
0024205564
-
The epidemiology of obsessive-compulsive disorder in 5 US states
-
Karno M, Golding JM, Sorenson SB, et al. The epidemiology of obsessive-compulsive disorder in 5 US states. Arch Gen Psychiatry 1988;45:1094-1099
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 1094-1099
-
-
Karno, M.1
Golding, J.M.2
Sorenson, S.B.3
-
2
-
-
0030666602
-
Epidemiology of obsessive-compulsive disorder: A world view
-
Sasson Y, Zohar J, Chopra M, et al. Epidemiology of obsessive-compulsive disorder: a world view. J Clin Psychiatry 1997;58(suppl 12):7-10
-
(1997)
J Clin Psychiatry
, vol.58
, Issue.SUPPL. 12
, pp. 7-10
-
-
Sasson, Y.1
Zohar, J.2
Chopra, M.3
-
3
-
-
0031450398
-
Treatment strategies for chronic and refractory obsessive-compulsive disorder
-
Rasmussen SA, Eisen JL. Treatment strategies for chronic and refractory obsessive-compulsive disorder. J Clin Psychiatry 1997;58(suppl 13):9-13
-
(1997)
J Clin Psychiatry
, vol.58
, Issue.SUPPL. 13
, pp. 9-13
-
-
Rasmussen, S.A.1
Eisen, J.L.2
-
4
-
-
0032972847
-
Obsessive-compulsive disorder in schizophrenia: Epidemiologic and biologic overlap
-
Tibbo P, Warneke L. Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. J Psychiatry Neurosci 1999;24:15-21
-
(1999)
J Psychiatry Neurosci
, vol.24
, pp. 15-21
-
-
Tibbo, P.1
Warneke, L.2
-
6
-
-
0029058311
-
Is there a relationship between clozapine and obsessive-compulsive disorder?
-
Ghaemi SN, Zarate CA, Popli AP, et al. Is there a relationship between clozapine and obsessive-compulsive disorder? Compr Psychiatry 1995;36:267-270
-
(1995)
Compr Psychiatry
, vol.36
, pp. 267-270
-
-
Ghaemi, S.N.1
Zarate, C.A.2
Popli, A.P.3
-
7
-
-
0031748592
-
Risperidone may worsen fluoxetine-treated OCD [letter]
-
Andrade C. Risperidone may worsen fluoxetine-treated OCD [letter]. J Clin Psychiatry 1998;59:255-256
-
(1998)
J Clin Psychiatry
, vol.59
, pp. 255-256
-
-
Andrade, C.1
-
8
-
-
0033846191
-
A double-blind placebo-controlled study of risperidone addition in serotonin uptake inhibitors-refractory obsessive-compulsive disorders
-
McDougle CJ, Epperson CN, Pelton GH, et al. A double-blind placebo-controlled study of risperidone addition in serotonin uptake inhibitors-refractory obsessive-compulsive disorders. Arch Gen Psychiatry 2000;57:794-801
-
(2000)
Arch Gen Psychiatry
, vol.57
, pp. 794-801
-
-
McDougle, C.J.1
Epperson, C.N.2
Pelton, G.H.3
-
9
-
-
0032722095
-
Obsessive compulsive disorder in patients with first episode schizophrenia
-
Poyurovsky M, Fuchs C, Weizman A. Obsessive compulsive disorder in patients with first episode schizophrenia. Am J Psychiatry 1999;156:1998-2000
-
(1999)
Am J Psychiatry
, vol.156
, pp. 1998-2000
-
-
Poyurovsky, M.1
Fuchs, C.2
Weizman, A.3
-
10
-
-
0038056535
-
Co-morbidity of obsessive compulsive disorders in recovered patients with bipolar disorder
-
Kruger S, Braunig P, Cooke RG. Co-morbidity of obsessive compulsive disorders in recovered patients with bipolar disorder. Bipolar Disord 2000;2:71-74
-
(2000)
Bipolar Disord
, vol.2
, pp. 71-74
-
-
Kruger, S.1
Braunig, P.2
Cooke, R.G.3
-
11
-
-
10044284081
-
Obsessive compulsive disorder in schizophrenia
-
Poyurovsky M, Weizman A, Weizman R. Obsessive compulsive disorder in schizophrenia. CNS Drugs 2004;18:989-1010
-
(2004)
CNS Drugs
, vol.18
, pp. 989-1010
-
-
Poyurovsky, M.1
Weizman, A.2
Weizman, R.3
-
12
-
-
18544390921
-
Emergence of compulsive symptoms with olanzapine treatment [letter]
-
Mahendran R. Emergence of compulsive symptoms with olanzapine treatment [letter]. Aust N Z J Psychiatry 2002;36:565
-
(2002)
Aust N Z J Psychiatry
, vol.36
, pp. 565
-
-
Mahendran, R.1
-
13
-
-
0001138748
-
Obsessive-compulsive symptoms with risperidone [letter with replies]
-
Mahendran R. Obsessive-compulsive symptoms with risperidone [letter with replies]. J Clin Psychiatry 1999;60:261-263
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 261-263
-
-
Mahendran, R.1
-
14
-
-
0024435153
-
The Yale-Brown Obsessive Compulsive Scale, 1: Development, use, and reliability
-
Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 1: development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011
-
(1989)
Arch Gen Psychiatry
, vol.46
, pp. 1006-1011
-
-
Goodman, W.K.1
Price, L.H.2
Rasmussen, S.A.3
-
15
-
-
0033000934
-
Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders
-
de Haan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry 1999;60:364-365
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 364-365
-
-
de Haan, L.1
Linszen, D.H.2
Gorsira, R.3
-
16
-
-
0036179508
-
Obsessive compulsive symptoms during treatment with olanzapine and risperidone: A prospective study of 113 patients with recent-onset schizophrenia or related disorders
-
de Haan L, Beuk N, Hoogenboom B, et al. Obsessive compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. J Clin Psychiatry 2002;63:104-107
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 104-107
-
-
de Haan, L.1
Beuk, N.2
Hoogenboom, B.3
-
17
-
-
0036785080
-
Risperidone-induced obsessive compulsive symptoms: A series of six cases
-
Alevizos B, Lykouras L, Zervas IM, et al. Risperidone-induced obsessive compulsive symptoms: a series of six cases. J Clin Psychopharmacol 2002;22:461-467
-
(2002)
J Clin Psychopharmacol
, vol.22
, pp. 461-467
-
-
Alevizos, B.1
Lykouras, L.2
Zervas, I.M.3
-
18
-
-
18844381122
-
Obsessive-compulsive symptoms in schizophrenia: Associated clinical features, cognitive function and medication status
-
Ongur D, Goff DC. Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophr Res 2005;75:349-362
-
(2005)
Schizophr Res
, vol.75
, pp. 349-362
-
-
Ongur, D.1
Goff, D.C.2
-
19
-
-
10044284081
-
Obsessive-compulsive disorder in schizophrenia: Clinical characteristics and treatment
-
Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs 2004;18:989-1010
-
(2004)
CNS Drugs
, vol.18
, pp. 989-1010
-
-
Poyurovsky, M.1
Weizman, A.2
Weizman, R.3
|